• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于生理的眼药代动力学计算建模方法。

Physiologically based ocular pharmacokinetic modeling using computational methods.

机构信息

Data Science and Digital Solutions, Alcon Vision LLC, Fort Worth, TX, USA.

Data Science and Digital Solutions, Alcon Vision LLC, Fort Worth, TX, USA.

出版信息

Drug Discov Today. 2019 Aug;24(8):1551-1563. doi: 10.1016/j.drudis.2019.05.039. Epub 2019 Jul 15.

DOI:10.1016/j.drudis.2019.05.039
PMID:31319151
Abstract

By explicitly representing ocular anatomy, computational fluid dynamic simulation methods model drug mass transport both within and between ocular tissue regions, providing reliable animal-to-human translation of bioavailability. Here, we apply physiologically based models to simulate ocular drug administration. A non-anatomical model is used that applies a simple theorem for calculating ocular bioavailability from a topical dose. A computational fluid dynamic model is also described that incorporates ocular physiology in anatomical models for rabbit, monkey and man. This second method applies material properties and boundary conditions for various tissues enabling simulation of fluid flows, pressures, temperatures, convection, and drug advection following various modes of administration. The method provides a regional distribution with a given tissue not available using standard compartmental models, and enables translation of results from animal experiments into predictions for human ocular pharmacokinetics (PK).

摘要

通过明确表示眼部解剖结构,计算流体动力学模拟方法可以模拟药物在眼部组织区域内和之间的质量传递,从而可靠地将生物利用度从动物转化到人类。在这里,我们应用基于生理学的模型来模拟眼部药物给药。使用一种非解剖模型,该模型应用一个简单的定理来计算局部剂量的眼部生物利用度。还描述了一种计算流体动力学模型,该模型将眼部生理学纳入兔、猴和人的解剖模型中。第二种方法适用于各种组织的材料特性和边界条件,从而能够模拟给药后各种模式下的流体流动、压力、温度、对流和药物对流。该方法提供了一种给定组织的区域分布,这是使用标准隔室模型无法获得的,并且能够将动物实验的结果转化为对人类眼部药代动力学(PK)的预测。

相似文献

1
Physiologically based ocular pharmacokinetic modeling using computational methods.基于生理的眼药代动力学计算建模方法。
Drug Discov Today. 2019 Aug;24(8):1551-1563. doi: 10.1016/j.drudis.2019.05.039. Epub 2019 Jul 15.
2
A comprehensive insight on ocular pharmacokinetics.关于眼部药代动力学的全面见解。
Drug Deliv Transl Res. 2016 Dec;6(6):735-754. doi: 10.1007/s13346-016-0339-2.
3
Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension.机制性眼部吸收建模和模拟在理解制剂特性对兔眼部生物利用度影响中的应用:以地塞米松混悬剂为例的研究
AAPS J. 2019 May 20;21(4):65. doi: 10.1208/s12248-019-0334-x.
4
General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.局部用眼部药物剂型的一般药代动力学模型。
Pharm Res. 2016 Nov;33(11):2680-90. doi: 10.1007/s11095-016-1993-2. Epub 2016 Jul 18.
5
[Ocular pharmacokinetics: Topical, intravitreal, and systemic drug application].[眼药代动力学:局部、玻璃体内及全身用药]
Ophthalmologe. 2014 Feb;111(2):104-6. doi: 10.1007/s00347-013-2930-y.
6
Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties.眼部药物传递系统的设计原则:药物载药量、释放率和材料性能的重要性。
Drug Discov Today. 2019 Aug;24(8):1446-1457. doi: 10.1016/j.drudis.2019.02.001. Epub 2019 Feb 7.
7
Computational Model of In Vivo Corneal Pharmacokinetics and Pharmacodynamics of Topically Administered Ophthalmic Drug Products.体内角膜局部用眼科药物制剂药代动力学和药效学的计算模型。
Pharm Res. 2023 Apr;40(4):961-975. doi: 10.1007/s11095-023-03480-6. Epub 2023 Mar 23.
8
Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.眼用制剂和接触镜经眼部给药到前房的机制模型研究。
Adv Colloid Interface Sci. 2016 Jul;233:139-154. doi: 10.1016/j.cis.2015.08.002. Epub 2015 Aug 14.
9
Prediction of Ocular Drug Distribution from Systemic Blood Circulation.从体循环预测眼内药物分布
Mol Pharm. 2016 Sep 6;13(9):2906-11. doi: 10.1021/acs.molpharmaceut.5b00729. Epub 2015 Dec 29.
10
[Ways to improve ocular bioavailability for topical applications].[提高局部应用眼部生物利用度的方法]
J Fr Ophtalmol. 2000 May;23(5):505-9; quiz 523.

引用本文的文献

1
An Ocular Exposure Prediction for Topical Atropine in Human Using Physiologically Based Pharmacokinetic Modeling.基于生理药代动力学模型的人用局部阿托品眼部暴露预测
AAPS J. 2025 May 2;27(4):89. doi: 10.1208/s12248-025-01052-7.
2
Computer modeling of bevacizumab drug distribution after intravitreal injection in rabbit and human eyes.兔眼和人眼玻璃体内注射贝伐单抗后药物分布的计算机模拟
J Pharm Sci. 2025 Feb;114(2):1164-1174. doi: 10.1016/j.xphs.2024.12.005. Epub 2024 Dec 16.
3
Mathematical Models of Ocular Drug Delivery.眼部药物输送的数学模型。
Invest Ophthalmol Vis Sci. 2024 Sep 3;65(11):28. doi: 10.1167/iovs.65.11.28.
4
Experimental and mathematical approaches for drug delivery for the treatment of wet age-related macular degeneration.用于治疗湿性年龄相关性黄斑变性的药物输送的实验和数学方法。
J Control Release. 2023 Nov;363:464-483. doi: 10.1016/j.jconrel.2023.09.021. Epub 2023 Oct 4.
5
Extended Pharmacokinetic Model of the Intravitreal Injections of Macromolecules in Rabbits. Part 2: Parameter Estimation Based on Concentration Dynamics in the Vitreous, Retina, and Aqueous Humor.兔眼玻璃体内注射大分子药物的扩展药代动力学模型。第2部分:基于玻璃体、视网膜和房水中药物浓度动态变化的参数估计。
Pharm Res. 2020 Oct 22;37(11):226. doi: 10.1007/s11095-020-02946-1.
6
Diffusion and Protein Corona Formation of Lipid-Based Nanoparticles in the Vitreous Humor: Profiling and Pharmacokinetic Considerations.脂质纳米粒子在玻璃体液中的扩散和蛋白冠形成:分析和药代动力学考虑。
Mol Pharm. 2021 Feb 1;18(2):699-713. doi: 10.1021/acs.molpharmaceut.0c00411. Epub 2020 Jul 8.